Genmab (NASDAQ:GMAB), a biotechnology company with a market capitalization of $16.91 billion specializing in cancer ...

By Kim Hyelin The human immune system, gene editors designed by artificial intelligence (AI), living biological robots and ...

MaxCyte Inc. (NASDAQ: MXCT) is a global developer of next-generation cell therapies. They provide crucial technology for cell ...

Binance Labs rebrands to YZi Labs, focusing on Web3, AI, and biotech with CZ mentoring startups and Ella Zhang at the helm.

Scientists have completed construction of the final chromosome in the worlds' first synthetic yeast genome following more than a decade of work, opening new possibilities for creating resilient, ...

With innovations in biopesticides, precision technology, and genetic engineering, the future of insecticides looks promising.

Wednesday, January 22, 2025 1:30 PM - Wednesday, January 22, 2025 3:00 PM ...

We recently published a list of the 12 Biotech Stocks with the Biggest Upside Potential. In this article, we are going to ...

Bhubaneswar: The International Conference on Blue Economy was organised in the city on Thursday which brought together 800 global participants to expl.